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Abstract
Protein-protein interactions defined by affinity purification and mass spectrometry (APMS) 
approaches suffer from high false discovery rates. Consequently, the candidate interaction lists 
must be pruned of contaminants before network construction and interpretation, historically an 
expensive and time-intensive task. In recent years, numerous computational methods have been 
developed to identify genuine interactions from hundreds revealed by APMS experiments. Here, 
comparative analysis of several popular algorithms revealed complementarity in their 
classification accuracies, which is supported by their divergent scoring strategies. As such, we 
used two accurate and computationally efficient methods as features for machine learning using 
the Random Forest algorithm. Additionally, we developed novel mathematical models to include a 
variety of indirect data, such as mRNA co-expression, gene ontologies and homologous protein 
interactions as features within the classification problem. We show that our method, which we call 
Spotlite, outperforms existing methods on four diverse and public APMS datasets. Because 
implementation of existing APMS scoring methods requires computational expertise beyond many 
laboratories, we created a user-friendly and fast web application for APMS data scoring, analysis, 
annotation and network visualization, for use on new and existing data (http://152.19.87.94:8080/
spotlite). The utility of Spotlite and its visualization platform for revealing physical, functional and 
disease-relevant characteristics within APMS data is established through a focused analysis of the 
KEAP1 E3 ubiquitin ligase.
INTRODUCTION
Mapping the global protein-protein interaction network and defining its dynamic 
reorganization during specific cell state changes will provide an invaluable and 
transformative knowledgebase for many scientific disciplines. Recent advancements in two-
hybrid technologies and affinity purification – mass spectrometry (APMS) have 
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dramatically increased protein connectivity information, and therefore a proteome-wide 
interaction map may be realized in the not-so-distant future. Specifically, technological and 
computational advancements in mass spectrometry-based proteomics have increased sample 
throughput, detection sensitivity and mass accuracy, all with decreasing instrumentation 
costs. Consequently, to date over 2,200 human proteins have been analyzed by APMS, as 
estimated through BioGRID and data presented herein (1). Similarly, the generation of 
arrayed human clone sets has revealed binary interactions among approximately 13,000 
proteins (HI-2012 Human Interactome, Center for Cancer Systems Biology). While both 
approaches detect direct protein interactions, only APMS can detect indirect interactions – 
though with limited ability to distinguish between the two types.
In general, APMS-based protein interaction experiments are performed by selectively 
purifying a specific protein, termed the bait, along with its associated proteins from a cell or 
tissue lysate. Mass spectrometry is then used to identify and more recently quantify the bait 
and all associated proteins within the affinity purified protein complex, collectively termed 
the prey. Though a prey’s presence supports its existence within a complex, high numbers of 
non-specific contaminants—owing largely to technical artifacts during the biochemical 
purification—lead to false protein complex identifications and therefore significantly 
hamper data interpretation. As such, numerous computational methods have been developed 
to differentiate between genuine APMS protein complex interactions and false-positive 
discoveries.
These algorithms can be broadly categorized based on which features of the APMS data are 
included and how the resulting network is mapped. Methods such as SAI, Hart, Purification 
Enrichment scores and Dice Coefficients use the binary presence of the protein as evidence 
for an interaction (2–8). More recently, computational approaches employed by SAINT (9), 
MiST (10), CompPASS (11) and the HGSCore (12) achieved improved scoring accuracy by 
taking advantage of label free quantification using spectral counts, a reflection of the 
abundance of a protein after purification. Additionally, these algorithms can also be 
categorized by whether they use a spoke or matrix model to represent protein connectivity 
(4). The spoke model represents only bait-prey interactions, while the matrix model – used 
by the Hart (7) and HGSCore methods – additionally represents all prey-prey interactions, 
resulting in a quadratic number of potential interactions per experiment instead of linear, and 
therefore contain an order of magnitude more interactions to test. Though the matrix model 
can detect more true complex co-memberships, it has the added difficulty of filtering prey 
pairs that form distinct complexes with the bait. Each method has its merits and has been 
successfully applied to APMS data; however, their widespread utilization has been limited.
In addition to using direct features from APMS experiments to predict the validity of 
putative protein-protein interactions, success in the de novo prediction of protein interactions 
has been achieved through the analysis of indirect data (13–16). Specifically, mRNA co-
expression has been shown to positively correlate with co-complexed proteins, and the Gene 
Ontology’s (GO) biological process and cellular component annotations have proven to be 
useful for interaction prediction by utilizing semantic similarity (17–19). Both co-expression 
and GO co-annotation are also commonly used metrics for evaluating predicted interactions. 
Sequence and structural homology at the domain and whole-protein level have established 
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themselves as powerful predictors as well (20, 21). Though individually useful, integration 
of these indirect sources using machine learning techniques such as Support Vector 
Machines (22), Random Forests (23), Naïve Bayes (24), and Logistic Regression (25) have 
further increased prediction accuracy. APMS data has also been used as a discriminative 
feature, however it was encoded as a binary value representing an interaction’s presence – 
far less powerful than the sophisticated APMS scoring methods now available (16).
Among the label free methods, only SAINT’s software is available for public use and 
requires compilation and command line execution – limiting its use for research groups 
lacking computational expertise (9). CompPASS provides a public web interface to search 
its data, but no option to employ the algorithm on private datasets (11). Aside from APMS 
scoring methods, numerous web applications are available for de novo protein-protein 
interaction prediction (26, 27). These methods do not incorporate new APMS data, and 
therefore provide an insufficient resource for researchers wishing to integrate their own 
experiments into the predictions.
Given the independent successes of using direct and indirect data to predict and score 
protein-protein interactions, we created Spotlite, a Random Forest-based (28) classifier to 
identify genuine interactions from human APMS experiments, one which utilizes features 
taken from APMS data and a variety of indirect data. To foster its use within the proteomic 
community, we developed and speed-optimized a web application for Spotlite execution on 
existing and novel datasets. In addition to providing an integrated network visualization tool, 
because all features employed within the machine learning algorithm are provided, the 




To develop a classification strategy capable of efficiently segregating false positive protein 
interactions from true interactions within APMS-derived data, we collected four publically 
available and well-diversified APMS datasets. These data were received directly from the 
authors of the respective publications and searched and filtered using the criteria described 
in their methods. The data contained spectral counts, baits, and preys for each experiment. 
For the purposes of establishing a classifier, we defined protein-protein interactions taken 
from the Human Interactome and BioGRID as known interactions. More specifically, 
protein-protein interactions were downloaded from BioGRID (1)(http://thebiogrid.org/ 
Release 3.1.89) and appended with the Human Interactome project’s two-hybrid data from 
The Center for Cancer Systems Biology at the Dana-Farber Cancer Institute (http://
interactome.dfci.harvard.edu/). Protein sequences and cross database accession mappings 
were downloaded from IPI (29)(http://www.ebi.ac.uk/IPI/ final releases) and UniProt/
SwissProt (30)(http://www.uniprot.org/ Release 05/2012). Protein domains were determined 
with PfamScan (31)(http://pfam.sanger.ac.uk/ Release 26.0) using an e-value threshold of 
0.05. Entrez Gene IDs, official symbols, aliases, and gene types were extracted from NCBI 
Gene’s FTP site, http://www.ncbi.nlm.nih.gov/gene (gene_history.gz and gene_info.gz - 
downloaded 05/26/12). Gene homolog data was downloaded from NCBI’s Homologene 
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(http://www.ncbi.nlm.nih.gov/homologeneBuild66). Pearson correlation coefficients for co-
expression data were downloaded from COXPRESdb (32) (http://coxpresdb.jp/) for Homo 
sapiens (version c3.1), Mus musculus (version c2.1), Drosophila melanogaster (version 
c1.0), Caenorhabditis elegans (version c1.0), Danio rerio (version c1.0), Gallus gallus 
(version c1.0), and Rattus norvegicus (version c2.0). Ontology hierarchies and annotations 
were downloaded on 05/26/12. The Gene Ontology supplied the biological process and 
cellular component ontology hierarchies, where the annotations were downloaded from 
NCBI Gene’s FTP site (33). The Mammalian Phenotype Ontology (relevant organism: Mus 
Musculus) hierarchy and annotations were downloaded from Mouse Genome Informatics 
(34)(http://www.informatics.jax.org/). The Human Phenotype Ontology’s hierarchy and 
annotations were downloaded from www.human-phenotype-ontology.org (35). The Disease 
Ontology annotations were taken from its associated publication’s supplemental data (http://
projects.bioinformatics.northwestern.edu/do_rif/) and the hierarchy from the OBO Foundry 
(36)(http://obofoundry.org/).
ID Mapping
IPI and UniProt accessions were directly mapped to Entrez Gene IDs using cross database 
accession mappings. If a direct mapping did not exist, indirect mappings were checked by 
finding accession to accession mappings (e.g. IPI to UniProt) and testing them for direct 
mappings. If multiple Gene IDs were identified as candidates, an arbitrary one was chosen. 
Similarly, Gene Symbols were directly mapped to Gene IDs. For Gene Symbols that did not 
match an Official Gene Symbol, gene aliases were queried and if multiple candidate IDs 
were found, one was chosen arbitrarily.
Machine Learning
We approached the probabilistic scoring of APMS protein-protein interactions as a binary 
classification problem in which the two classes are: 1) pairs of proteins that directly or 
indirectly form a complex together (positive class), and 2) pairs of proteins that are never 
members of the same complex (negative class). The classifier chosen was a Random Forest 
(28)(Weka v3.6.7 implementation, (37)), which was previously shown to demonstrate high 
classification accuracy for protein-protein interaction prediction (16). The features used to 
characterize a pair of putative co-complexed proteins were gene co-expression patterns in 
humans and their homologs in six different species, as well as semantic similarity scores for 
the pair’s ontological annotations for biological processes, cellular components, diseases, 
mutant phenotypes, and mouse homologs’ mutant phenotypes. Additionally, domain-domain 
binding affinities, homologous interactions, and label-free APMS scoring methods 
CompPASS and the HGSCore were used. Only spoke model interactions were tested, 
because CompPASS was not designed for the matrix model, as well as for computational 
efficiency. The classifier was trained specifically for human data, using a training set 
comprised of four published APMS datasets (Table 1). Ultimately, the Random Forest 
classifier outputs the probability a candidate APMS protein-protein interaction belongs to 
the positive or negative class of co-complexed proteins.
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Feature Calculation for Random Forest
For classification, all putative APMS-derived protein-protein interactions were characterized 
by direct and indirect features. Direct features, which are derived from the output of the 
APMS experiment, included the HGSCore score and a modified CompPASS WD-score. The 
HGSCore is capable of testing matrix model interactions, however, for implementation 
within Spotlite, we restricted it to spoke model interactions. The HGSCore first converts 
spectral counts to normalized spectral abundance factors (NSAF (38)), then scales them by 
setting the smallest value to 1, and finally taking the integer value of the square root – 
resulting in a Tn value for each protein in an experiment. The HGSCore is then defined as:
We computed a modified CompPASS score to account for increased variability within 
biological replicates. The original CompPASS WD-score equation was designed such that 
each bait protein would be analyzed by APMS two independent times. The equation was 
defined as:
To permit greater variability within the number of duplicate biological replicate 
experiments, as is required when analyzing disparate datasets originating from many 
independent laboratories, we modified the exponent to have a smaller effect on 
reproducibility:
Where n is the total number of replicates for bait i. Figure S1 shows the modification’s 
improvement over the original WD-score for each of the four analyzed datasets. In cases 
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where both proteins of an interaction are tested as baits, the larger CompPASS score was 
taken.
In addition to these direct APMS-dependent features, indirect characteristics of a putative 
protein-protein interaction were also employed within the Random Forest classification. The 
correlation between mRNA expression patterns of two genes was quantified using the 
Pearson correlation coefficient (PCC). In total, seven co-expression features – one for each 
species mentioned in Data Collection – were added to the classification model. The human 
feature is the PCC for the pair of human genes to be classified. There often exist multiple 
homologs of a gene within a different species; therefore the co-expression features for genes 
i and j, in non-human species k, were defined as the maximum PCC among the set of 
homolog pairs for that species, Hijk:
A separate feature was used for each of the five ontologies: biological process, cellular 
component, human phenotype, mouse phenotype, and human disease. Semantic similarity 
scores were utilized to determine how similar two gene’s sets of annotations, A and B, were 
to each other, and used as the feature value. We computed semantic similarity scores using 
Resnik’s MAX method (17). This method searches for the set of nearest common ancestors, 
C, among all pairs of annotations between two genes and returns the maximum information 
content.
We used the Maximum Likelihood Estimation (20) method to calculate the probability of 
each potential domain-domain interaction, λmn. This required all two-hybrid interactions for 
Saccharomyces cerevisiae from BioGRID. S. cerevisiae was chosen for its high interactome 
coverage, leading to a more accurate estimation of domain-domain interaction probabilities. 
A single protein sequence was used for each gene, with preference given to the longest 
UniProt/SwissProt sequence, followed by the longest IPI sequence. A false positive rate of 
0.005 and a false negative rate of 0.37 were used, which are required parameters of the 
method. Our feature – The probability that two proteins interact via their domains – was 
calculated using the set of potentially interacting domains, Dij, present within the proteins:
The final feature used was the number of known distinct interactions among the homologs 
of the two proteins:
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Co-expression and ontologies features are subject to missing values due to lack of 
microarray probes and lack of annotations, respectively, and were treated as null. The 
Random Forest algorithm is designed to handle these during training and classification. Null 
values for ontology features were assigned to candidate interactions where at least one of the 
proteins has no annotations aside from the root of the ontology. Null values for co-
expression features were assigned when COXPRESdb did not have data for the feature.
Training Set Construction
To segregate false positive protein interactions from true interactions, we trained and tested 
candidate classifiers using a supervised learning approach on four published human APMS 
datasets. Specifically, the four datasets analyzed described protein complexes associated 
with unique biological functions — deubiquitination (DUB)(11), autophagy (AIN)(39), 
chromatin remodeling (40)(TIP49), and transcriptional regulation (Complexome)(41) (Table 
I). These datasets range extensively in their number of experiments, interaction network 
connectivity and purification technique, resulting in a diverse training set capable of testing 
the generalizability of our method. All bait and prey identifiers were mapped to Entrez Gene 
IDs using the method described in the ID Mapping section. Interactions tested in both 
directions in a dataset were included only once. Within each APMS dataset, the CompPASS 
and HGSCore feature was normalized to have a mean of zero and a standard deviation of 
one. Candidate interactions annotated as physical interactions in BioGRID were used the 
positive class, excluding interactions represented by a single publication employing 
CompPASS or the HGSCore, as this would create a bias towards one of the methods. To 
avoid an extremely unbalanced training set, the negative set was created by uniformly 
sampling the unknown interactions from each dataset to contain 10 times the number of the 
dataset’s known interactions.
Model Training and Evaluation
The Random Forest classifier was trained by creating 100 decision trees and splitting from a 
subset of 4 randomly selected features at each node. The positive class was given a weight 
of 10, while the negative class received a weight of 1. For cross-validation, each full dataset 
was tested with a classifier trained on the three remaining sampled datasets. Some overlaps 
were present among datasets; therefore interactions present in the dataset being tested were 
removed from the training set, avoiding the mistake of testing on trained data. In the case 
where an interaction was in multiple training datasets, one of the instances was selected at 
random. The metric for success was the receiver operating characteristic (ROC) curve. We 
treat all unknown interactions as the negative set. Though real interactions exist in this set, 
the number of false interactions is expected to greatly exceed the number of false negatives, 
making the ROC curve an appropriate metric.
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False Discovery Rate Calculation
We used the probabilistic method employed by ProteinProphet to compute false discovery 
rates (FDR). First, interaction probabilities calculated by the Random Forest are sorted in 
descending order. Next, the FDR is calculated for the top x interactions using the equation:
Finally, the user selects a FDR threshold, and the corresponding minimum interaction 
probability to accept is outputted.
FLAG Affinity Purification and Western Blot Analyses
For FLAG affinity purification, HEK293T cells were lysed in 0.1% NP-40 lysis buffer (10% 
glycerol, 50mM HEPES, 150 mM NaCl, 2mM EDTA, 0.1% NP-40) containing protease 
inhibitor mixture (1861278, Thermo Scientific, Waltham, MA) and phosphatase inhibitor 
(78427, Thermo Scientific, Waltham, MA). Cell lysates were cleared by centrifugation and 
incubated with FLAG resin (F2426, Sigma-Aldrich Corporation, St. Louis, MO) before 
washing with lysis buffer and eluting with NuPAGE loading buffer (Life Technologies, 
Carlsbad, CA). Detection of proteins by Western blot was performed using the following 
antibodies: anti-FLAG M2 monoclonal (Sigma-Aldrich Corporation, St. Louis, MO), anti-
FAM117b (21768, ProteinTech, Chicago, IL), anti-MAD2L1 (A300-301A, Bethyl Labs, 
Montgomery, TX), anti-MCM3 (A300-192A, Bethyl Labs, Montgomery, TX), anti-SLK 
(A300-499A, Bethyl Labs, Montgomery, TX), anti-βactin polyclonal (A2066, Sigma-
Aldrich Corporation, St. Louis, MO), anti-KEAP1 polyclonal (ProteinTech. Chicago, IL), 
anti-DPP3 polyclonal (97437, Abcam, Cambridge, MA), and anti-VSV polyclonal 
(A190-131A, Bethyl Labs, Montgomery, TX).
Mass Spectrometry
For FLAG affinity purification of KEAP1, HEK293T cells stably expressing FLAG-KEAP1 
were lysed in 0.1% NP-40 lysis buffer (10% glycerol, 50mM HEPES, 150 mM NaCl, 2mM 
EDTA, 0.1% NP-40) containing protease inhibitor mixture (1861278, Thermo Scientific, 
Waltham, MA) and phosphatase inhibitor (78427, Thermo Scientific, Waltham, MA). 
Approximately 50mg of whole cell lysate was cleared by centrifugation and incubated with 
20μL of packed FLAG resin (F2426, Sigma-Aldrich Corporation, St. Louis, MO) before 
washing 5 times with lysis buffer. Following an on-beads digestion with FASP Protein 
Digestion Kit (Protein Discovery, San Diego, CA), tryptic peptides were cleaned up by C18 
Spin Column (Thermo Scientific, Waltham, MA), then separated by reverse phase nano-
HPLC using a nanoAquity UPLC system (Waters Corp, Milford, MA). Peptides were first 
trapped in a 2 cm trapping column (75 μm ID, Michrom Magic C18 beads of 5.0 μM particle 
size, 200 Å pore size) and then separated on a self-packed 25 cm column (75 μm ID, 
Michrom Magic C18 beads of 3.0μM particle size, 100 Å pore size) at room temperature. 
The flow rate was 200 nl/min over a gradient of 1% buffer B (0.1% formic acid in 
acetonitrile) to 30% buffer B in 180 min. Then a following wash raised buffer B to 70%. 
The identity of the eluted peptides was determined with an in-line LTQ-Orbitrap Velos mass 
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spectrometer (Thermo Scientific, Waltham, MA). The ion source was operated at 2.0–2.4 
kV with ion transfer tube temperature set at 275 °C. Full MS scan (300–2000 m/z) was 
acquired in Orbitrap with 60,000 resolution setting, data-dependent MS2 spectra were 
acquired in LTQ by collision induced dissociation (CID) using the 20 most intense ions. 
Precursor ions were selected based on charge states (1, 2 or 3) and intensity thresholds 
(above 2000) from the full scan, dynamic exclusion (one repeat during 30-s, a 60-s 
exclusion time window) was also taken into account. The polysiloxane lock mass of 
445.120030 was used throughout spectral acquisition.
Mass Spectrometry Data Analysis
All raw data were converted to mzXML format before a search of the resultant spectra using 
Sorcerer™-SEQUEST® (build 4.0.4, Sage N Research, Milpitas, CA) and the 
Transproteomic Pipeline (42)(TPP v4.3.1). Data were searched against the human 
UniProtKB/Swiss-Prot sequence database (Release 2011_08) supplemented with common 
contaminants, i.e. porcine (Swiss-Prot P00761) and bovine (P00760) trypsin, and further 
concatenated with its reversed copy as a decoy (40,494 total sequences). Search parameters 
used were a precursor mass between 400 and 4500 amu, up to 2 missed cleavages, 
precursor-ion tolerance of 3 amu, accurate mass binning within PeptideProphet (43), semi-
tryptic digestion, a static carbamidomethyl cysteine modification, and variable methionine 
oxidation. Two KEAP1 experiments labeled MA128 were searched as one experiment 
through Sorcerer’s interface, as they constituted the same sample run through the mass 
spectrometer in two halves. False discovery rates (FDR) were determined by ProteinProphet 
(44) and minimum protein probability cutoffs resulting in a 1% FDR were selected 
individually for each experiment. ProteinProphet results for each APMS experiment were 
stored in a local Prohits database (45) and Cytoscape v2.8.2(46) was used for network 
visualization. Unsearched data is available through the ProteoCommon.org Tranche network 




Combining APMS Scoring Methods Enriches for Previously Reported Protein Interactions
Existing spectral count-based APMS scoring methods demonstrate a high level of accuracy 
in predicting protein complex co-membership, thus making them appealing features for 
classification. A direct comparison of three popular and fundamentally distinct scoring 
algorithms—HGSCore, CompPASS and SAINT—revealed overlapping and complementary 
prediction accuracies (Figure 1). Specifically, the three methods were separately applied to 
each dataset, and individual thresholds were determined to achieve a 5% false positive rate, 
treating all un-annotated interactions as the negative set. The unions and intersections of 
each method’s set of accepted interactions were then compared (Figure 1). Although some 
methods performed better than others, each of the three approaches was capable of 
identifying known protein-protein interactions disjoint from the remaining two. As expected, 
no single method identified all of the previously annotated protein interactions. That said, 
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the intersection of the three datasets showed strong enrichment for validated protein 
interactions. As such, the HGSCore and CompPASS (with a modified WD score) were 
chosen as features to broaden and strengthen the confidence of selected interactions, and for 
their computational speed.
Spotlite Outperforms Previous APMS Scoring Methods
To further improve upon interaction predictions, we chose to include into Spotlite data 
outside of APMS that had previously been shown to correlate with co-complexed proteins. 
These indirect sources of evidence were mRNA co-expression patterns among seven 
species, GO annotation similarity, phenotypic similarity, domain-domain binding affinities, 
and homologous interactions. Each was encoded into a feature, and along with the HGSCore 
and CompPASS, describe a putative pair of interacting proteins. Then, using the Random 
Forest algorithm, these interactions were predicted to be genuine based on the values of their 
corresponding feature vector.
In order to benchmark Spotlite against previous methods, we performed a variation of cross-
validation by training a Random Forest classifier on each combination of three datasets and 
then testing on the remaining fourth dataset (Figure 2). Spotlite consistently outperformed 
SAINT, CompPASS and HGSCore based on ROC curve analysis and partial area indexes, 
which demonstrates greater sensitivity and specificity toward known interactions in the 
BioGRID database. These data also demonstrate that the discriminatory patterns learned 
from each dataset were generally applicable, as classification accuracy was superior across 
all cross-validation instances. To generate our final classifier for use in the web application, 
all four of the datasets were used for training. Table II shows each feature’s coverage within 
the Spotlite database and its respective importance based on the Random Forest’s Gini 
Index. As expected, the HGSCore and CompPASS were the two most important features 
used for distinguishing between known and false or unknown co-complexed proteins. 
Additionally, to determine the increase in accuracy due to the inclusion of indirect data, we 
calculated the number of misclassified interactions while performing stratified five-fold 
cross-validation with all features included, and compared it to training with the APMS 
features only. Impressively, misclassified interactions occurred at a rate of 34.95% using 
only APMS-derived features, and decreased to 30.58% after inclusion of the indirect 
features.
Spotlite Web Application for Public Use
We have made Spotlite available to the research community through a user-friendly web 
application that follows a simple workflow (Figure 3). Users may upload a tab-delimited file 
containing each experiment, its associated purification technique, bait, prey, and each prey’s 
spectral count. An option for using the publically available APMS data deposited within 
Spotlite allows the smaller datasets of individual researchers to take advantage of the 
existing larger collection (using only the data of the same purification technique), thereby 
improving the filtering of the common contaminants by the HGSCore and CompPASS 
features. Next, the indirect feature data, which has been pre-computed for every potential 
pair of genes, is retrieved from the database. Finally, the data are classified by the Random 
Forest classifier. The false discovery rates are calculated and users can then explore and 
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visualize their results through the website or export them to a spreadsheet. For our largest 
available dataset, the Complexome, the entire process takes approximately two minutes to 
complete after the initial file upload. To maintain privacy, all uploaded APMS data and 
results are deleted after 24 hours of upload, or destroyed on command by the user.
Spotlite Analysis of KEAP1 APMS Data
To demonstrate its utility, performance and ease in identifying true interacting proteins from 
APMS data, we affinity purified the KEAP1 E3 ubiquitin ligase from HEK293T cells and 
analyzed the resulting data within Spotlite (Table S1). Specifically, cells engineered to 
stably express FLAG-tagged KEAP1 were detergent solubilized and subjected to FLAG 
affinity purification and shotgun mass spectrometry. Using biological duplicate KEAP1 
APMS experiments and a reference set of an additional 22 FLAG purifications performed on 
18 different baits, the KEAP1 protein interaction network was scored and visualized with 
Spotlite. The unfiltered KEAP1 dataset contained 534 prey proteins, of which 24 were 
annotated in BioGRID as being previously identified as KEAP1 interactors; 18 through 
high-throughput experiments and 6 using low-throughput methods (Figure 4A). After 
application of Spotlite and a global 10% FDR threshold, the network reduced to 35 proteins, 
of which three were shown to be genuine through low-throughput experiments, nine through 
high-throughput methods and 23 putative novel interactors (Figure 4B). Next, we selected 
eight KEAP1 interacting proteins that passed Spotlite thresholding for further validation by 
immunoprecipitation and Western blot analysis: MCM3, DPP3, SLK, MCC, MCMBP, 
MAD2L1, SQSTM1 and FAM117B. Of these, five were previously annotated as high-
throughput interactors, one by low-throughput assays and two were novel interactors (MCC 
and FAM117B). Impressively, all eight endogenously expressed proteins co-purified with 
FLAG-tagged KEAP1 (Figure 4C).
In addition to providing the Random Forest classification score, the Spotlite web application 
lists the following individual features for each protein pair: HGSCore (HGS), CompPASS, 
gene ontologies for biological process (BP) and cellular component (CC), gene co-
expression for seven species (CXP), domain-domain binding score (Domain), number of 
homologous interactions (Homo int), shared phenotypes (Phen), shared human diseases 
(Disease) and whether the proteins have previously been shown to interact (Known?). As an 
example, Spotlite’s visualization for the KEAP1-MAD2L1 interaction is provided in Figure 
5. Both proteins affect growth and size in mice, specifically postnatal growth retardation 
with KEAP1 and decreased embryo size with MAD2L1. Additionally, both proteins are 
encoded by mRNAs which positively correlate across human tissues, and both proteins are 
strongly associated with oncogenesis.
DISCUSSION
Protein mass spectrometry is quickly becoming a staple technology in academic 
laboratories. The rapidly decreasing instrumentation costs, often pre-packaged and 
streamlined bioinformatic pipelines and enhanced mass accuracy and scan speeds are no 
doubt driving the recent explosion of protein mass spectrometry data. With similar advances 
in two-hybrid technologies, it is now economically feasible to pursue, and in fact achieve a 
Goldfarb et al. Page 11













proteome-wide connectivity map. A key step in this endeavor, or in the comprehensive 
definition of any biomolecule—whether that be genomics, transcriptomics, metabolomics or 
proteomics—is the computational scoring and integration of the resulting datasets.
After performing hundreds of APMS experiments directed at mapping protein connectivity 
central to various signal transduction pathways, we and others quickly found the high rate of 
false-positive identification rate limiting and exceedingly expensive. Appreciating the need 
for an accessible and accurate APMS scoring algorithm, we developed Spotlite as a new 
computational tool capable of revealing true interactions from the contaminants within 
APMS data. Importantly, we deployed Spotlite through a web-based application which 
provides open access and full transparency to any interested scientist. The inclusion of 
indirect data as features within Spotlite’s Random Forest classification not only provides 
4.35% increased prediction accuracy but also yields valuable information regarding shared 
biological function, phenotype and disease relationships among protein pairs.
Given the success of established scoring approaches employed by CompPASS, HGSCore 
and SAINT, we initially set out to define their relative performance on various APMS 
datasets, and by doing so to identify the most accurate approach for implementation within a 
classification scheme. However, our analyses revealed valuable complementarity between 
the algorithms, which appeared partially dependent upon the network architecture of the 
analyzed APMS dataset. As such, we found greatest success by providing the Random 
Forest classifier with both CompPASS and HGSCore; given its relatively slow computation 
speed, inclusion of SAINT was not feasible for a web-based application. Though Spotlite’s 
performance shows a marked improvement over existing methods, its success is governed 
by the small number of known protein interactions (positive dataset), the lack of validated 
non-interactions (negative dataset), and mislabeled instances used during training. 
Furthermore, many indirect features lacked high coverage, resulting in missing values. 
While these limitations may place a ceiling on current performance, data will continue to 
pour in and fill the gaps. We expect Spotlite to improve over time due to increased feature 
coverage, and re-training of the classifier as larger interaction networks become available.
A critical aspect of any supervised learning approach is the selection of a gold standard 
dataset containing accurately labeled examples that are representative of the future data to be 
classified. While many protein-protein interactions are annotated, proteins known not to 
interact are rare—the Negatome being the sole available resource and of prohibitively small 
size (47). In addition to our approach of using known interactions contained in the APMS 
data as our positive class and random samples from the APMS unknown interactions as the 
negative, we explored alternative strategies for defining our training set, namely the 
common practice for protein-protein interaction prediction of using all known interactions 
and a random sample for the noninteracting class. Classifiers were trained by including all 
known interactions, with missing values for the HGSCore and CompPASS, and also by 
including both known and randomly sampled unknowns, neither of which were able to 
match the accuracy of training on APMS interactions alone. A possible reason for this is a 
deemphasized role of the APMS scoring methods. It is also important to note that as we are 
predicting co-complexed proteins, our set of known interactions included both direct and co-
complexed interactions.
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Presently, Spotlite supports human APMS data exclusively; however, it can be extended to 
other species by compiling the data for their features. Aside from analyzing another species’ 
data using the current workflow, we envision the possibility of using APMS from multiple 
species to improve predictions through homologous interactions, which is already a 
powerful feature in our implementation. Along these lines, merging datasets from various 
laboratories has the potential to further increase accuracy. While this is currently an optional 
feature within Spotlite, it should be done with great care as contaminants will vary due to 
differences in cell lines, mass spectrometers and protocols, leading to improperly high 
CompPASS and HGSCore values for mutually exclusive contaminants which now appear 
more unique. This combined analysis of datasets is an area of future research.
A major focus of our research focuses on the development of proteomic and functional 
genomic technologies to define the mechanics and disease contribution of the KEAP1. The 
KEAP1 protein functions as a CUL3-based E3 ubiquitin ligase, most well-known for its 
ubiquitination of the NFE2L2 transcription factor (48–50). Recently, somatic inactivating 
mutations in KEAP1 have been reported in a variety of solid human tumors, particularly in 
lung cancer (51–59). The leading model posits that KEAP1 inactivation results in 
constitutive NFE2L2 transcriptional activation of antioxidant and pro-survival genes (60, 
61). APMS analysis of KEAP1 followed by Spotlite scoring and a 10% FDR filter revealed 
35 associated proteins. Of the eight proteins validated to reside within KEAP1 protein 
complexes by IP/Western blot, the indirect data—as visualized through the Spotlite web 
application—drew attention to the KEAP1-MAD2L1 protein association. Specifically, the 
MAD2L1 protein is known to function pivotally within the spindle assembly checkpoint 
complex, which holds cells in metaphase until chromosome-spindle attachment is complete 
(62–64). Like KEAP1, MAD2L1 is strongly associated with cancer; its over-expression 
drives chromosomal instability and aneuploidy (65, 66). MAD2L2 is also known to be 
ubiquitinated, although the E3 ubiquitin ligase is unknown (67, 68). An intriguing possibility 
is that KEAP1 ubiquitinates MAD2L1 to control its activity and/or stability. Within cancer 
systems, somatic mutation of KEAP1 may coincide with elevated MAD2L1 activity, thus 
driving aneuploidy.
In conclusion, we have provided a user-friendly web application for predicting complex co-
membership from APMS data. This web application employs a novel, Random Forest 
classifier that integrates existing, proven APMS scoring approaches, gene co-expression 
patterns, functional annotations, phenotypic observations, protein domains, and homologous 
interactions, which we have shown outperforms existing APMS scoring methods.
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Figure 1. Comparison of accepted interactions using various APMS scoring methods
Venn diagrams show sets of previously established interactions using a 5% false positive 
rate threshold for each scoring method. The counts of known interactions are in bold and the 
counts of false or unknown interactions are in parentheses. Areas are proportional to the 
total number of interactions within their respective subsets.
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Figure 2. Random Forest cross-validation and comparison
Receiver operating characteristic curves for each dataset. Values in parentheses represent 
partial area indexes.
Goldfarb et al. Page 19













Figure 3. Schematic of Spotlite workflow
Dashed lines represent optional paths selected by the user. Upon uploading a new dataset, 
the user can choose to retrieve public APMS data of the same affinity purification technique 
before calculating scores for CompPASS and the HGSCore.
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Figure 4. Spotlite application to KEAP1 APMS
(A) The unfiltered spoke model network of KEAP1 represents 534 nodes. Nodes were sized 
by total spectral counts, as indicated within the key. Green nodes represent proteins reported 
in BioGRID to form complexes with KEAP1. (B) Spotlite filtered spoke model network 
using a false discovery rate threshold of 10%. Eight unlabeled nodes represent possible 
contaminants. (C) FLAG affinity purified protein complexes from HEK293T cells stably 
expressing FLAG-GFP or FLAG-KEAP1 were analysed by Western blot for the indicated 
endogenously expressed proteins.
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Figure 5. Screenshots of Spotlite visualization for KEAP1-MAD2L1 data
Column headers on the main results screen are the following: Spotlite score (Classifier), 
HGSCore (HGS), CompPASS, gene ontologies for biological process (BP) and cellular 
component (CC), gene co-expression for seven species (CXP), domain-domain binding 
score (Domain), number of homologous interactions (Homo int), shared phenotypes (phen), 
shared human diseases (Disease) and whether the proteins have previously been shown to 
interact (Known?; H=high throughput, L=low throughput). Transparency is provided 
through a series of user-triggered pop-up windows which details the information used to 
generate the Spotlite feature score.
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Table II
Feature importances for Random Forest classifier
Feature Typea Database Coverageb Training Coveragec Gini Importanced
HGSCore Direct 11.79% 100.00% 1.88
CompPASS Direct 11.79% 100.00% 1.54
Human co-expression Indirect 69.29% 92.92% 1.37
Chicken co-expression Indirect 11.89% 22.33% 1.25
Fish co-expression Indirect 4.51% 17.11% 1.24
Fly co-expression Indirect 2.20% 9.85% 1.18
Mouse co-expression Indirect 29.31% 47.77% 1.13
Worm co-expression Indirect 1.36% 5.48% 1.09
Rat co-expression Indirect 13.63% 26.50% 1.08
Disease ontology Functional 3.98% 11.69% 1.02
Mouse phenotype ontology Functional 8.53% 20.75% 0.95
Human phenotype ontology Functional 0.80% 1.91% 0.93
Biological process GO Functional 48.66% 84.33% 0.81
Homologous interactions Sequence 85.86% 99.53% 0.77
Cellular localization GO Functional 61.69% 86.02% 0.71
Domain-domain binding affinity Sequence 70.32% 88.33% 0.05
a
Classification of the type of evidence a feature represents with respect to co-complexed proteins.
b
Percentage of all potentially co-complexed pairs of genes within the Spotlite database containing values for a feature. HGSCore and CompPASS 
coverages represent the percentage of bait-prey interactions tested, including preys with 0 spectra. Ontology coverages computed by taking the 
percentage of gene pairs in which both genes have ≥ 1 annotation. Homologous interactions coverage - both genes must have a known homolog in 
the same species. Domain-domain binding affinity coverage - both genes must contain a known domain.
c
Coverages calculated identically to b - restricted to the training dataset.
d
Feature importance measure computed by Random Forests.
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